OR WAIT null SECS
October 04, 2018
The agency approved Insmed’s Arikayce (amikacin liposome inhalation suspension), for the treatment of lung disease caused by a group of bacteria, Mycobacterium avium complex (MAC) in a limited population of patients with the disease who do not respond to conventional treatment (refractory disease).
September 17, 2018
Guenter Nadler, director of Business Development at Aptar Pharma, will present an insight briefing on new drug-delivery trends in treating upper and lower respiratory tract issues on Wednesday, Oct. 9, 2018 at CPhI Worldwide.
September 06, 2018
Emergent BioSolutions is set to acquire Adapt Pharma, a pharmaceutical company focused on addressing the opioid overdose and addiction crisis, in a deal worth up to $735 million.
The purchase of Novartis’ cystic fibrosis products TOBI Podhaler and TOBI solution is expected to strengthen Mylan’s global respiratory portfolio.
August 03, 2018
Formulation characteristics must be optimized, following device selection, to achieve the desired performance for the capsule loaded in the dry powder inhaler.
June 14, 2018
Recipharm adds inhalation drug manufacturing capacity with the acquisition of Sanofi’s Holmes Chapel, UK site.
May 02, 2018
Choice of carrier can have a significant impact on the capsule filling process as well as the performance of the DPI formulation.
April 02, 2018
Particle engineering using jet milling or spray drying can be used to obtain appropriate particle characteristics for inhalation drug products.
March 02, 2018
Aston Particle Technologies has developed a technology that produces functionalized particles in a one-step, environmentally friendly process.
January 25, 2018
Hovione has installed a new MG2 Tekna Precision Capsule filler at its Portugal site.